Investor Presentaiton slide image

Investor Presentaiton

88K 63K INVESTOR 20 DAY 23 125K Guardant360 has been the primary volume growth driver 29K 50K 2018 2019 2020 2021 2022 26K 10K 21K 19K 16K 2018 2019 2020 2021 2022 GUARDANTâ„¢ 44% Clinical Testing Volume CAGR 26% Biopharma Testing Volume CAGR 143
View entire presentation